Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
The guideline panel provided recommendations related to the diagnosis of IPF.
The guideline panel provided recommendations related to the diagnosis of IPF.
Among patients with ILD associated with systemic sclerosis, the annual rate of decline in FVC was lower with nintedanib than with placebo; no clinical benefit of nintedanib was ...
h-index: Number of publications with at least h citations each.